P3 Health Partners Inc. PIII
Institutional shares held
18.8 Million
0
calls
0
puts
Total value of holdings
$144M
$0
calls
$0
puts
Market Cap
$319M
41,578,900
Shares Out.
Institutional ownership
45.31%
# of Institutions
34
We take great care to ensure that the data presented and summarized in this overview for P3 Health Partners Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PIII
View all-
Alyeska Investment Group, L.P. Chicago, IL9.05MShares$69.4 Million0.01% of portfolio
-
Ci Private Wealth, LLC Miami, FL1.87MShares$14.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$14 Million0.0% of portfolio
-
Emfo, LLC1.43MShares$11 Million0.58% of portfolio
-
Trinity Financial Advisors LLC1.28MShares$9.8 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA980KShares$7.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY411KShares$3.15 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny406KShares$3.11 Million0.0% of portfolio
-
Abundance Wealth Counselors400KShares$3.07 Million0.01% of portfolio
-
Ubs Group Ag236KShares$1.81 Million0.0% of portfolio
Latest Institutional Activity in PIII
Top Purchases
Top Sells
About PIII
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Insider Transactions at PIII
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.5 P/Share
|
|
Sep 12
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.52 P/Share
|
|
Sep 11
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.56 P/Share
|
|
Sep 10
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.52 P/Share
|
|
Sep 09
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.53 P/Share
|
|
Sep 06
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.49 P/Share
|
|
Sep 05
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.49 P/Share
|
|
Sep 04
2024
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.1%
|
$0
$0.49 P/Share
|
|
May 24
2024
|
Leavitt Legacy, LLC |
BUY
Open market or private purchase
|
Indirect |
7,974,481
+32.03%
|
-
|
|
Jan 09
2024
|
Sherif Abdou Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
483,868
+23.13%
|
-
|
|
Jan 09
2024
|
Amir Bacchus Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
287,118
+12.53%
|
-
|
|
Dec 31
2023
|
Sherif Abdou Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
483,868
-30.09%
|
$483,868
$1.41 P/Share
|
|
Dec 31
2023
|
Amir Bacchus Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
287,118
-14.32%
|
$287,118
$1.41 P/Share
|
|
Oct 23
2023
|
Gregory N. Kazarian Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Lawrence B. Leisure Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Mark Thierer Director |
BUY
Grant, award, or other acquisition
|
Direct |
433,121
+50.0%
|
-
|
|
Oct 23
2023
|
Mary A Tolan Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Thomas Edmunds Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Jeffrey G Park Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
8.61M
Shares
From
2
Insiders
| Open market or private purchase | 8.61M shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders